Neutron Capture Enhances Dose and Reduces Cancer Cell Viability in and out of Beam During Helium and Carbon Ion Therapy
International Journal of Radiation Oncology*Biology*Physics · 2024
DOI: 10.1016/j.ijrobp.2024.02.052 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2024. Verfasst von Nicholas Howell und 21 weiteren Autor:innen. Beteiligte Einrichtung: Australian Nuclear Science and Technology Organisation, Lucas Heights, Australia. Hauptthemen laut MEDLINE: Helium, Glioblastoma, Cell Survival, Phantoms, Imaging. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: UICC.
Abstract (Originalsprache)
PURPOSE: Neutron capture enhanced particle therapy (NCEPT) is a proposed augmentation of charged particle therapy that exploits thermal neutrons generated internally, within the treatment volume via nuclear fragmentation, to deliver a biochemically targeted radiation dose to cancer cells. This work is the first experimental demonstration of NCEPT, performed using both carbon and helium ion beams with 2 different targeted neutron capture agents (NCAs). METHODS AND MATERIALS: Human glioblastoma cells (T98G) were irradiated by carbon and helium ion beams in the presence of NCAs [10B]-BPA and [157Gd]-DOTA-TPP. Cells were positioned within a polymethyl methacrylate phantom either laterally adjacent to or within a 100 × 100 × 60 mm spread out Bragg peak (SOBP). The effect of NCAs and location relative to the SOBP on the cells was measured by cell growth and survival assays in 6 independent experiments. Neutron fluence within the phantom was characterized by quantifying the neutron activation of gold foil. RESULTS: Cells placed inside the treatment volume reached 10% survival by 2 Gy of carbon or 2 to 3 Gy of helium in the presence of NCAs compared with 5 Gy of carbon and 7 Gy of helium with no NCA. Cells placed adjacent to the treatment volume showed a dose-dependent decrease in cell growth when treated with NCAs, reaching 10% survival by 6 Gy of carbon or helium (to the treatment volume), compared with no detectable effect on cells without NCA. The mean thermal neutron fluence at the center of the SOBP was approximately 2.2 × 109 n/cm2/Gy (relative biological effectiveness) for the carbon beam and 5.8 × 109 n/cm2/Gy (relative biological effectiveness) for the helium beam and gradually decreased in all directions. CONCLUSIONS: The addition of NCAs to cancer cells during carbon and helium beam irradiation has a measurable effect on cell survival and growth in vitro. Through the capture of internally generated neutrons, NCEPT introduces the concept of a biochemically targeted radiation dose to charged particle therapy. NCEPT enables the established pharmaceuticals and concepts of neutron capture therapy to be applied to a wider range of deeply situated and diffuse tumors, by targeting this dose to microinfiltrates and cells outside of defined treatment regions. These results also demonstrate the potential for NCEPT to provide an increased dose to tumor tissue within the treatment volume, with a reduction in radiation doses to off-target tissue.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Australian Nuclear Science and Technology Organisation, Lucas Heights, Australia.
- Wollongong Isotope Geochronology Laboratory, School of Earth, Atmospheric and Life Sciences, University of Wollongong, Wollongong, Australia.
- School of Electrical and Data Engineering, University of Technology Sydney, Ultimo, Australia.
- Centre for Medical Radiation Physics, University of Wollongong, Wollongong, Australia.
- National Institutes for Quantum Sciences and Technology, Chiba, Japan.
- School of Chemistry, The University of Sydney, Sydney, Australia; The University of Sydney Nano Institute, Sydney, Australia.
Förderung
- UICC
Zitieren
APA
Howell, N., Middleton, R. J., Sierro, F., Fraser, B. H., Wyatt, N. A., Chacon, A., Bambery, K. R., Livio, E., Dobie, C., Bevitt, J. J., Davies, J., Dosseto, A., Franklin, D. R., Garbe, U., Guatelli, S., Hirayama, R., Matsufuji, N., Mohammadi, A., Mutimer, K., …, & Safavi-Naeini, M. (2024). Neutron Capture Enhances Dose and Reduces Cancer Cell Viability in and out of Beam During Helium and Carbon Ion Therapy. International Journal of Radiation Oncology*Biology*Physics. https://doi.org/10.1016/j.ijrobp.2024.02.052
Vancouver
Howell N, Middleton RJ, Sierro F, Fraser BH, Wyatt NA, Chacon A, et al. Neutron Capture Enhances Dose and Reduces Cancer Cell Viability in and out of Beam During Helium and Carbon Ion Therapy. International Journal of Radiation Oncology*Biology*Physics. 2024. doi:10.1016/j.ijrobp.2024.02.052
BibTeX
@article{Howell2024,
author = {Howell, Nicholas and Middleton, Ryan J and Sierro, Frederic and Fraser, Benjamin H and Wyatt, Naomi A and Chacon, Andrew and Bambery, Keith R and Livio, Elle and Dobie, Christopher and Bevitt, Joseph J and Davies, Justin and Dosseto, Anthony and Franklin, Daniel R and Garbe, Ulf and Guatelli, Susanna and Hirayama, Ryoichi and Matsufuji, Naruhiro and Mohammadi, Akram and Mutimer, Karl and Rendina, Louis M and Rosenfeld, Anatoly B and Safavi-Naeini, Mitra},
title = {Neutron Capture Enhances Dose and Reduces Cancer Cell Viability in and out of Beam During Helium and Carbon Ion Therapy},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2024},
doi = {10.1016/j.ijrobp.2024.02.052}
}
EUVIMED